Last $5.25 USD
Change Today -0.10 / -1.87%
Volume 1.1M
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

orexigen therapeutics inc (OREX) Snapshot

Open
$5.33
Previous Close
$5.35
Day High
$5.41
Day Low
$5.23
52 Week High
03/19/14 - $7.82
52 Week Low
10/13/14 - $3.11
Market Cap
646.6M
Average Volume 10 Days
2.8M
EPS TTM
$-0.56
Shares Outstanding
123.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OREXIGEN THERAPEUTICS INC (OREX)

orexigen therapeutics inc (OREX) Related Businessweek News

View More BusinessWeek News

orexigen therapeutics inc (OREX) Details

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include NB32, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and Empatic that has completed Phase II clinical trials. Orexigen Therapeutics, Inc. has collaboration agreement with Takeda Pharmaceutical Company Limited to develop and commercialize NB32 in the United States, Canada, and Mexico. The company was founded in 2002 and is headquartered in La Jolla, California.

50 Employees
Last Reported Date: 03/13/14
Founded in 2002

orexigen therapeutics inc (OREX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $625.0K
Acting Chief Financial Officer, Principal Acc...
Total Annual Compensation: $370.0K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $370.0K
Head of Global Contrave Program and Senior Vi...
Total Annual Compensation: $370.0K
Chief Commercial Officer
Total Annual Compensation: $296.0K
Compensation as of Fiscal Year 2013.

orexigen therapeutics inc (OREX) Key Developments

Orexigen Therapeutics, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 08:00 AM

Orexigen Therapeutics, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 08:00 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Michael A. Narachi, Chief Executive Officer, President and Director.

Orexigen Therapeutics, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 12:30 PM

Orexigen Therapeutics, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 12:30 PM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States.

Orexigen Therapeutics, Inc. Presents at Brean Capital Life Sciences Summit, Nov-24-2014

Orexigen Therapeutics, Inc. Presents at Brean Capital Life Sciences Summit, Nov-24-2014 . Venue: Convene (Formerly Sentry Centers), 730 3rd Avenue, New York, New York, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $5.25 USD -0.10

OREX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OREX.
View Industry Companies
 

Industry Analysis

OREX

Industry Average

Valuation OREX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 19.3x
Price/Book 38.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 13.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit www.orexigen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.